ARCHIVES

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

This article is from The Cancer Letter archive.

Vol. 31 No. 44 | December 2, 2005

Download PDF Visit The Full Archive

Related Articles

Organ Systems Program Adds Workshops On Lung, Colorectal Cancer

January 26, 1990

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

In Brief: Women’s Health Group Asks Magazines To Stop Accepting Tobacco Advertising

June 5, 1998

ODAC Chairman: Time Was Tight For Meeting

November 10, 1995

NIH, NCI Get Higher Funding In 2014 Budget

January 17, 2014

In Brief: NCAB to Hear Program Review, Reports On AIDs Monoclonal Antibodies, Cancer Research at Drew

November 25, 1983